StonvexLoading…
StonvexStonvexStonvexCore line items from AQST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $44.55M | $57.56M | $50.58M | $47.68M |
Operating Income | $-71.05M | $-30.77M | $-15.10M | $-42.07M |
Net Income | $-83.78M | $-44.14M | $-7.87M | $-54.41M |
EPS (Diluted) | $-0.78 | $-0.51 | $-0.13 | $-1.12 |
Total Assets | $160.43M | $101.42M | $57.42M | $57.07M |
Total Liabilities | $194.09M | $161.58M | $163.91M | $175.62M |
Cash & Equivalents | $121.17M | $71.55M | $23.87M | $27.27M |
Free Cash Flow OCF − CapEx | $-52.99M | $-35.92M | $-7.38M | $-10.84M |
Shares Outstanding | 122.04M | 91.41M | 68.53M | 54.83M |